News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
339,886 Results
Type
Article (15739)
Company Profile (97)
Press Release (324050)
Multimedia
Podcasts (25)
Webinars (9)
Section
Business (100272)
Career Advice (471)
Deals (18751)
Drug Delivery (52)
Drug Development (34027)
Employer Resources (58)
FDA (8781)
Job Trends (8357)
News (164651)
Policy (14566)
Tag
Academia (1351)
Academic (1)
Accelerated approval (2)
Allergies (45)
Alliances (28949)
ALS (38)
Alzheimer's disease (717)
Antibody-drug conjugate (ADC) (74)
Approvals (8883)
Artificial intelligence (169)
Autoimmune disease (9)
Automation (12)
Bankruptcy (98)
Best Places to Work (6957)
BIOSECURE Act (11)
Biosimilars (63)
Biotechnology (54)
Bladder cancer (41)
Brain cancer (9)
Breast cancer (161)
Cancer (1273)
Cardiovascular disease (109)
Career advice (422)
Career pathing (9)
CAR-T (67)
Cell therapy (212)
Cervical cancer (14)
Clinical research (28750)
Collaboration (616)
Compensation (231)
Complete response letters (7)
COVID-19 (1579)
CRISPR (24)
C-suite (163)
Cystic fibrosis (41)
Data (1298)
Denatured (17)
Depression (22)
Diabetes (139)
Diagnostics (4817)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (16)
Drug discovery (58)
Drug pricing (21)
Drug shortages (12)
Duchenne muscular dystrophy (42)
Earnings (34080)
Editorial (12)
Employer branding (11)
Employer resources (51)
Events (52086)
Executive appointments (504)
FDA (9533)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (399)
Gene editing (54)
Generative AI (13)
Gene therapy (168)
GLP-1 (364)
Government (1961)
Grass and pollen (4)
Guidances (42)
Healthcare (9298)
Huntington's disease (2)
IgA nephropathy (20)
Immunology and inflammation (44)
Indications (23)
Infectious disease (1677)
Inflammatory bowel disease (75)
Inflation Reduction Act (1)
Influenza (35)
Intellectual property (63)
Interviews (56)
IPO (8195)
IRA (9)
Job creations (1776)
Job search strategy (391)
Kidney cancer (4)
Labor market (8)
Layoffs (168)
Leadership (7)
Legal (2648)
Liver cancer (41)
Lung cancer (222)
Lymphoma (86)
Machine learning (3)
Management (15)
Manufacturing (210)
MASH (40)
Medical device (7396)
Medtech (7400)
Mergers & acquisitions (10954)
Metabolic disorders (339)
Multiple sclerosis (38)
NASH (12)
Neurodegenerative disease (39)
Neuropsychiatric disorders (8)
Neuroscience (973)
NextGen: Class of 2025 (2455)
Non-profit (2129)
Now hiring (21)
Obesity (169)
Opinion (65)
Ovarian cancer (31)
Pain (33)
Pancreatic cancer (43)
Parkinson's disease (73)
Partnered (12)
Patents (102)
Patient recruitment (70)
Peanut (28)
People (32588)
Pharmaceutical (31)
Pharmacy benefit managers (1)
Phase I (7286)
Phase II (11498)
Phase III (12048)
Pipeline (751)
Policy (48)
Postmarket research (1192)
Preclinical (2725)
Press Release (61)
Prostate cancer (60)
Psychedelics (12)
Radiopharmaceuticals (156)
Rare diseases (170)
Real estate (3926)
Recruiting (23)
Regulatory (11146)
Reports (19)
Research institute (1405)
Resumes & cover letters (53)
Rett syndrome (2)
RNA editing (1)
RSV (25)
Schizophrenia (37)
Series A (70)
Series B (48)
Service/supplier (4)
Sickle cell disease (32)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (21)
Startups (1605)
State (1)
Stomach cancer (8)
Supply chain (49)
Tariffs (11)
The Weekly (8)
Vaccines (407)
Venture capitalists (11)
Weight loss (95)
Women's health (18)
Worklife (2)
Date
Today (35)
Last 7 days (468)
Last 30 days (1420)
Last 365 days (18770)
2025 (6154)
2024 (19884)
2023 (22245)
2022 (31702)
2021 (34042)
2020 (32293)
2019 (23997)
2018 (18233)
2017 (16983)
2016 (16242)
2015 (18474)
2014 (13726)
2013 (11209)
2012 (12132)
2011 (11818)
2010 (10393)
Location
Africa (378)
Alabama (17)
Alaska (5)
Arizona (86)
Arkansas (7)
Asia (24928)
Australia (4089)
California (3120)
Canada (1036)
China (446)
Colorado (128)
Connecticut (121)
Delaware (101)
Europe (53029)
Florida (469)
Georgia (106)
Hawaii (1)
Idaho (25)
Illinois (249)
India (25)
Indiana (230)
Iowa (5)
Japan (144)
Kansas (42)
Kentucky (9)
Louisiana (3)
Maine (32)
Maryland (417)
Massachusetts (2442)
Michigan (168)
Minnesota (187)
Mississippi (1)
Missouri (59)
Montana (20)
Nebraska (9)
Nevada (29)
New Hampshire (51)
New Jersey (1132)
New Mexico (16)
New York (971)
North Carolina (580)
North Dakota (7)
Northern California (1346)
Ohio (139)
Oklahoma (7)
Oregon (11)
Pennsylvania (729)
Puerto Rico (6)
Rhode Island (19)
South America (568)
South Carolina (8)
Southern California (1201)
Tennessee (54)
Texas (437)
United States (12370)
Utah (92)
Virginia (73)
Washington D.C. (30)
Washington State (284)
West Virginia (1)
Wisconsin (34)
339,886 Results for "acm global laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle
December 13, 2024
·
3 min read
Press Releases
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 19, 2024
·
8 min read
Drug Development
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, announced positive topline results from a Phase I trial of ACM-001, the Company’s first clinical-stage development program.
September 5, 2023
·
4 min read
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Genetown
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date.
April 22, 2024
·
4 min read
Press Releases
Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
September 4, 2024
·
3 min read
Business
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors
ACM Biolabs announces the appointment of David Lawrence as Non-Executive Director.
April 11, 2023
·
3 min read
Press Releases
Investing in Research and Welcoming Global Talent Strengthens America
May 1, 2025
·
1 min read
Press Releases
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
November 13, 2024
·
2 min read
1 of 33,989
Next
